BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cillóniz C, Amaro R, Torres A. Pneumococcal vaccination. Curr Opin Infect Dis 2016;29:187-96. [PMID: 26779776 DOI: 10.1097/QCO.0000000000000246] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Nakahashi-Ouchida R, Yuki Y, Kiyono H. Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases. Hum Vaccin Immunother 2018;14:2189-93. [PMID: 29624474 DOI: 10.1080/21645515.2018.1461298] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
2 Vila-Corcoles A, Ochoa-Gondar O, de Diego C, Satue E, Aragón M, Vila-Rovira A, Gomez-Bertomeu F, Magarolas R, Figuerola-Massana E, Raga X, Perez MO, Ballester F. Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study. BMC Infect Dis 2018;18:196. [PMID: 29699550 DOI: 10.1186/s12879-018-3096-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
3 Masters IB, Isles AF, Grimwood K. Necrotizing pneumonia: an emerging problem in children? Pneumonia (Nathan) 2017;9:11. [PMID: 28770121 DOI: 10.1186/s41479-017-0035-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 7.6] [Reference Citation Analysis]
4 Feldman C, Anderson R. Epidemiology, virulence factors and management of the pneumococcus. F1000Res 2016;5:2320. [PMID: 27703671 DOI: 10.12688/f1000research.9283.1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
5 Liao H, Peng X, Gan L, Feng J, Gao Y, Yang S, Hu X, Zhang L, Yin Y, Wang H, Xu X. Protective Regulatory T Cell Immune Response Induced by Intranasal Immunization With the Live-Attenuated Pneumococcal Vaccine SPY1 via the Transforming Growth Factor-β1-Smad2/3 Pathway. Front Immunol 2018;9:1754. [PMID: 30116243 DOI: 10.3389/fimmu.2018.01754] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
6 Perret C, Le Corre N, Castro-Rodriguez JA. Emergent Pneumonia in Children. Front Pediatr 2021;9:676296. [PMID: 34222146 DOI: 10.3389/fped.2021.676296] [Reference Citation Analysis]
7 Richter L, Schmid D, Kanitz EE, Zwazl I, Pöllabauer E, Jasinska J, Burgmann H, Kundi M, Wiedermann U. Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program. PLoS One 2019;14:e0210081. [PMID: 30629620 DOI: 10.1371/journal.pone.0210081] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
8 Domínguez-Alegría AR, Pintado V, Barbolla I. Treatment and prevention of invasive pneumococcal disease. Rev Clin Esp (Barc) 2018;218:244-52. [PMID: 29448981 DOI: 10.1016/j.rce.2018.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Passanisi S, Dipasquale V, Romano C. Vaccinations and Immune Response in Celiac Disease. Vaccines (Basel) 2020;8:E278. [PMID: 32517026 DOI: 10.3390/vaccines8020278] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]